Next report date
Report period
Q1 2024
EPS estimate
−6.96MXN
Revenue estimate
1.16 BMXN
−2.78 BMXN
3.17 BMXN
37.00 M
Om Mirum Pharmaceuticals, Inc.
Sektor
Bransch
VD
Christopher Peetz
Webbplats
Huvudkvarter
Foster City
Employees (FY)
264
Grundat
2018
FIGI
BBG0121CJQL5
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
